Page 499 - Problem-Based Feline Medicine
P. 499

23 – THE BLEEDING CAT  491


              – As with ACT, there is no direct correlation  – PIVKA clotting time is similar to PT, but a
                between the degree of prolongation of aPTT and  different thromboplastin is used to activate
                the risk for bleeding. The risk for bleeding at a  coagulation, and the  plasma is diluted,
                given aPTT value will vary with the underlying  resulting in longer clotting times. The test
                disorder causing the coagulation abnormality. In  was introduced as a  more sensitive assay
                general, for a given disorder, the longer the aPTT  than the standard PT for monitoring war-
                value the more likely the risk of bleeding, but  farin therapy in humans. The  assay is more
                there are no precise values defining the risk.  sensitive both because the thromboplastin is
            ● Prothrombin time (PT).                           more sensitive to factor X deficiency, and
              – This test is similar to the aPTT, except that a  because the longer clotting times facilitate
                thromboplastin with tissue factor-like activity is  detection of subtle changes. It is also believed,
                added in excess to the test system, thus mimick-  but not proven, that the test is more sensitive
                ing the extrinsic system. The assay should only  than the PT to detect vitamin K deficiency or
                be performed in a laboratory that has validated  antagonism because the PIVKAs (uncarboxy-
                its assay for use in cats.                     lated clotting factors, see Vitamin K antago-
              – Collect sample as for aPTT.                    nist poisoning, below) inhibit the thromboplastin
              – Prolonged PT > 20–25% of control sample        and the factor X conversion of prothrombin to
                and/or outside the normal range indicates a    thrombin.
                defect in the extrinsic or common system of    – PIVKA time is a modified PT, and does not
                coagulation.                                     actually measure concentration of PIVKAs.
                – It may also be beneficial to submit an addi-  – The test was first introduced as the Throm-
                  tional control sample from a clinically nor-   botest™, and this name is used interchangeably
                  mal cat collected and handled in exactly the   with PIVKA. The former is recommended to
                  same manner as the patient sample in order     avoid the confusion that arises from the term
                  to detect artifactual prolongation of the PT.   PIVKA.
                    When comparing serial test results, results  – PIVKA time is more sensitive than PT to detect
                  from one laboratory cannot be directly com-  subclinical and clinical coagulopathies in cats
                  pared against results from another laboratory  due to vitamin K deficiency.
                  because of differences in methodology, includ-  – Most cats (> 95%) with a bleeding tendency
                  ing use of different thromboplastins. To facili-  due to vitamin K deficiency will have a pro-
                  tate comparison in humans an international     longed PIVKA time.
                  normalized ratio (INR) may be calculated as  – It is controversial whether or not PIVKA time
                                              ISI
                  INR = (patient PT/mean normal PT) , where      is more sensitive than the PT for the detection
                  ISI represents the international sensitivity   of vitamin K antagonism in dogs. This has not
                  index of the thromboplastin. The validity of   been evaluated in cats. Certainly any cat with
                  using INR in cats has not been extensively     clinical hemorrhage due to vitamin K antago-
                  evaluated.                                     nist poisoning will have a prolonged PT.
                – PT results are typically shorter than aPTT     PIVKA time may be more useful than PT for
                  results.                                       the monitoring of warfarin therapy for pro-
              – As with ACT and aPTT, there is no direct corre-  phylaxis of thromboembolism in cats with
                lation between the degree of prolongation of PT  cardiomyopathy.
                and the risk for bleeding. The risk for bleeding at  – PIVKA time is not specific for vitamin K defi-
                a given PT value will vary with the underlying  ciency or antagonism. Similar to the PT, it will
                disorder causing the coagulation abnormality. In  be prolonged in any disorder affecting fac-
                general, for a given disorder, the longer the PT  tors II, VII, IX and X, including congenital
                value the more likely the risk of bleeding, but  factor VII deficiency and some cases of DIC.
                there are no precise values defining the risk.  – Collect sample as for PT and aPTT.
            ● Proteins induced by vitamin K antagonism or    – Although the Thrombotest is a simple test for a
              absence (PIVKA).                                 reference laboratory to perform, it is not as
   494   495   496   497   498   499   500   501   502   503   504